Galapagos | GLPG - Stock


Galapagos reported EUR22.95M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
argenx SE USD 340.62M 66.61M Jun/2025
AstraZeneca USD 6.59B 126M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
Genmab DKK 13M 1000K Jun/2025
Gilead Sciences USD 1.77B 11M Dec/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Incyte USD 101.06M 17.61M Dec/2025
Merck EUR 4.51B 42M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Novartis USD 6.42B 114M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025